GLP-1 Receptor Agonist Evidence: Risks and Expert Guidance
GLP-1 Clinical Relevance #55Moderate Clinical Relevance Relevant context for GLP-1 prescribers; interpret with care. ⚕ GLP-1 News | CED Clinic Clinical CommentaryEvidence ReviewGLP-1 Receptor AgonistType 2 DiabetesObesity…
Cannabis for Nerve Pain: Mixed Evidence From 22 Trials, No Clear Winners Yet
Collectively, CBM treatments may improve pain scores, but study limitations such as small sample sizes and study durations, high placebo response rates, and trial unblinding because of the psychoactive effects of cannabinoids all hinder data…
Opioids and Cannabis: An Uncertain Combination?
Clinical commentary on research requires accessible peer-reviewed abstracts for evidence-based analysis. This PubMed link appears invalid, preventing responsible clinical review of the study methodology and findings.
Week in Weed – April 25, 2026 – StratCann
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Industry NewsRegulatory UpdatesClinical…
Medicinal Cannabis Matters: Friday Roundup – 24 April 2026 – Medicann
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Clinical PracticeEvidence ReviewMedical…
#ICYMI Our Zoe Mowery explored a pioneering Virginia Tech study on how cannabis use …
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Research QualityMedia LiteracyEvidence…
Lobsters in the News April 3, 2026 – Lobster Institute – The University of Maine
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Research QualityEvidence ReviewClinical…
Week in Weed – April 4, 2026 – StratCann
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Clinical PracticeEvidence ReviewCannabis…
Cannabis-based interventions might help a little with neuropathic pain – Study Summary
✦ New CED Clinical Relevance #80High Clinical Relevance Strong evidence or policy relevance with direct clinical implications. ⚒ Cannabis News | CED Clinic Neuropathic PainPain…
Major review finds “very little evidence” for cannabis treating anxiety, PTSD, or psychotic …
✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Mental HealthPtsdEvidence…
